Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Description of Warfarin and NOAC Utilization Patterns Including Initiation, Switching, and Discontinuation

NCT01847560 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01847560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01847560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Description of Warfarin and NOAC Utilization Patterns Including Initiation, Switching, and Discontinuation
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 17, 2013
Completion date
November 1, 2017
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation